American HealthCare Capital is pleased to present a high-margin toxicology laboratory available for sale in Hawaii. The lab has been in business for over a decade and focuses on clients in the substance abuse space. CAP certified and in-network with all local insurance companies in the state, the company is perfectly positioned for substantial growth into a full-service medical laboratory by adding infectious disease, molecular, clinical, and wellness panels. The lab is locally branded and well entrenched in the community, which is vital for operating a business in Hawaii.

In 2022, revenues were $2.88 million with an adjusted EBITDA of $1.14 million. 2023 is off to a strong start, with H1 revenues coming in at $1.5 million and an adjusted EBITDA of $495,000. For the full year 2023, revenues are projected to be $3.3 million with an adjusted EBITDA of $1.25 million due to increased margins with the recent changes to the sales team’s compensation structure and reduced fixed operating expenses as a percent of growing revenues.

The staff is aware of the sale and intends to remain with the organization. The asking price for this opportunity is $6.9 million, inclusive of almost $350,000 of lab equipment. The real estate is worth approximately $600,000.

If you would like to learn more, please use the link on the right-hand side of the page to execute our NDA. You will need to copy the Listing Code (Example: TXMC1A) and Listing Title (Example: $1 Million Home Health Agency in Texas) from the summary above to complete the NDA.